showed that the upregulation of IL17F in mCRC promotes tumor invasion by inducing EMT transition (61) and elevated levels of Th17-associated cytokines in advanced-stage mCRC are associated with poorer overall survival and possible resistance to chemotherapy (62). The gene discussed is IL17F; the disease is neoplasm.